The global health organization now officially backs drugs like Wegovy for obesity management. But it might be more symbolic than anything else.

Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease December 9, 2025 4:15 ...

FDA has given tentative approval to Lupin’s Siponimod tablets, a bioequivalent version of Mayzent, to treat people with ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...

America learned during the pandemic that it should never depend on our adversaries for our necessities. But if President ...